Reuters logo
BRIEF-Fate Therapeutics says FDA cleared third IND application for Fate-NK100​
August 8, 2017 / 7:17 PM / in 4 months

BRIEF-Fate Therapeutics says FDA cleared third IND application for Fate-NK100​

Aug 8 (Reuters) - Fate Therapeutics Inc:

* Says ‍U.S. Food and Drug Administration cleared third Investigational New Drug (IND) application for Fate-NK100​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below